Mental Health

Learn about the intersection of mental health and contraception, with evidence-based guidance on contraceptive options for patients with psychiatric conditions.

A new study reveals that consuming high-glycemic foods during the third trimester of pregnancy may impact infant temperament and emotional health.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study suggests that sex-based differences in the kynurenine pathway may contribute to depression risk in adolescents, offering insights for personalized treatment approaches.

A new study highlights the importance of analyzing racial and ethnic subgroups to better understand prenatal depression diagnoses, symptom severity, and disparities in treatment.

A recent study found that a solution-focused approach significantly enhances mental well-being, sleep quality, and reproductive health in women of advanced maternal age undergoing in vitro fertilization.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

New research highlights the link between postpartum posttraumatic stress disorder and sexual dysfunction, emphasizing the need for early screening and trauma-informed care.

Sexual inactivity worsens SSRI side effects in women, but gepirone-ER shows fewer impacts.

A found that adding personal coaching to electronic mindfulness-based interventions significantly lowers anxiety and depression in pregnant women, offering a low-cost, accessible mental health solution.

Researchers have identified key neuroactive steroid imbalances in the third trimester that may predict postpartum depression risk, paving the way for earlier intervention and preventive treatments.

A study finds that esketamine during cesarean delivery may reduce postpartum depression risk, though further research is needed to confirm its safety and efficacy.

Nicola F. Tavella, MPH, dives into his team's research on postpartum depression and unplanned cesarean delivery, which was presented at SMFM's 2025 Pregnancy Meeting.

A study found that prenatal cannabis use does not significantly alleviate depression or stress, emphasizing the need for safer mental health treatments during pregnancy.

Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.

A new study highlights a significant association between spontaneous miscarriage and increased risks of anxiety and depression, especially among women with low social support.

A new study underscores the critical need for gynecologists and mental health professionals to collaborate in managing anxiety, depression, and sexual dysfunction in women with endometriosis, driven by chronic pain and related comorbidities.

A new study highlights how depression may drive dysmenorrhea through shared genetic pathways, emphasizing the need for mental health screening and holistic care for women.

In a recent study, mothers and fathers with simultaneous parental leave after birth were more likely to utilize mental health care services than those without simultaneous parental leave.

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

A study presented at the 2024 Annual Meeting of The Menopause Society, found that women who reported physical intimate partner violence also demonstrated decreased working memory performance over time.

In a recent study, women with urinary incontinence were more likely to experience postpartum depression at both under and over 6 months after delivery.

A year after zuranolone’s FDA approval for postpartum depression on August 3, 2023, prescribers and a patient weigh in about the medication’s success in alleviating symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Reunion Neuroscience Inc. initiates phase 2 trial of RE104, a novel short-duration psychedelic treatment for postpartum depression, aiming to provide rapid and effective relief for affected mothers.

Effective management of attention-deficit/hyperactivity disorder during pregnancy involves comprehensive preconception counseling and meticulous perinatal planning, as highlighted in a recent study.

A recent study revealed a 36% increased risk of cardiovascular disease among women with perinatal depression, highlighting the need for incorporating reproductive health assessment into cardiovascular health evaluations.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study found that maternal psychological distress during the COVID-19 pandemic is associated with reduced white matter and other brain volumes in newborns, highlighting potential long-term impacts on child development.

A recent found that postpartum depression rates do not differ among women treated with intravenous ferric carboxymaltose, intravenous ferric derisomaltose, or oral ferrous sulphate for postpartum anemia.